T1	Nutrient 13 42	arabinoxylan-oligosaccharides
T2	Population 75 91	healthy subjects
T3	Methodology 95 142	randomised, placebo-controlled cross-over study
T4	Population 205 227	healthy human subjects
T5	Nutrient 231 260	arabinoxylan-oligosaccharides
T6	Nutrient 262 266	AXOS
T7	Nutrient 327 339	arabinoxlyan
T8	Physiology 281 307	partial enzymic hydrolysis
T9	Population 373 389	healthy subjects
T10	Methodology 418 465	randomised, placebo-controlled cross-over study
T11	Nutrient 486 490	AXOS
T12	Biospecimen 616 621	blood
T13	Methodology 709 775	subjects completed a questionnaire about gastrointestinal symptoms
T14	Biospecimen 791 796	urine
T15	Metabolite 837 845	p-cresol
T16	Metabolite 850 856	phenol
T17	Biospecimen 879 885	faeces
T18	Methodology 944 957	real-time PCR
T19	Biospecimen 997 1002	urine
T20	Biospecimen 1007 1013	faeces
T21	Chemical 1265 1277	Blood lipids
T22	Nutrient 1189 1193	AXOS
T23	Nutrient 1298 1302	AXOS
T24	DECREASES 1498 1521	significantly decreased
T25	Nutrient 1539 1543	AXOS
T26	Microorganism 1566 1580	bifidobacteria
T27	INCREASES 1586 1609	significantly increased
T28	Nutrient 1633 1637	AXOS
T29	Nutrient 1705 1709	AXOS
T30	Microorganism 1713 1727	bifidobacteria
T31	AFFECTS 1695 1701	effect
T32	Nutrient 1785 1789	AXOS
T33	Nutrient 1844 1848	AXOS
T34	INCREASES 1856 1865	increases
T35	Microorganism 1873 1887	bifidobacteria
T36	DECREASES 1892 1899	reduces
T37	Metabolite 1900 1926	urinary p-cresol excretion
T38	Metabolite 1428 1454	Urinary p-cresol excretion
T39	AFFECTS 1307 1342	no statistically significant effect
T40	Physiology 1359 1384	gastrointestinal symptoms
T41	Measurement 1109 1125	blood parameters
T42	AFFECTS 1131 1141	influenced
T43	Methodology 868 873	GC-MS
T44	Measurement 652 666;690 700	haematological parameters
T45	Measurement 671 700	clinical chemistry parameters
T46	Physiology 53 71	prebiotic activity
T47	Physiology 163 179	prebiotic effect
T48	Physiology 1416 1426	flatulence
T49	INCREASES 1399 1412	mild increase
T50	Nutrient 1811 1820	prebiotic
T51	Nutrient 315 326	wheat fibre
E1	DECREASES:T24 Theme:T38 Agent:T25
E2	INCREASES:T27 Theme:T26 Agent:T28
E3	AFFECTS:T31 Agent:T29 Theme:T30
E4	INCREASES:T34 Agent:T33 Theme:T35
E5	DECREASES:T36 Agent:T33 Theme:T37
E6	AFFECTS:T39 Agent:T23 Theme:T40
E7	AFFECTS:T42 Theme:T41 Agent:T22
E8	INCREASES:T49 Theme:T48 Agent:T23
A1	Factuality E6 Negated
N1	Reference T7 CHEBI:28427	arabinoxylan
N2	Reference T15 CHEBI:17847	p-cresol
N3	Reference T16 CHEBI:33853	phenols
N4	Reference T21 OCHV:41502	blood lipid
N5	Reference T26 NCBITAXON:1678	Bifidobacterium
N6	Reference T30 NCBITAXON:1678	Bifidobacterium
N7	Reference T35 NCBITAXON:1678	Bifidobacterium
N8	Reference T40 OCHV:C0426576	gastrointestinal symptoms
N9	Reference T48 NCIT:C37954	Flatulence
N10	Reference T50 MESH:D056692	Prebiotics
